Literature DB >> 11129226

Influence of intestinal flora on the development of fibrosis and cirrhosis in a rat model.

J L Plummer1, C J Ossowicz, C Whibley, A H Ilsley, P D Hall.   

Abstract

BACKGROUND AND AIMS: The gut flora play a significant role in the disposition of many foreign substances, as well as producing nutrients and toxins that may be absorbed and reach the liver. This study examines the influence of antibiotic-induced alterations in gut flora on the development of hepatic fibrosis in a rat model.
METHODS: Thirty-six male Porton rats were fed alcohol (3.9 g/kg per day) in the drinking water and exposed to carbon tetrachloride (CCl4) vapor (80 p.p.m.) for 6 h each night, five nights per week. Half were also given neomycin (330 mg/kg per day) and polymyxin B (105 mg/kg per day) in the drinking water. Fecal cultures were carried out at 0, 3, 8 and 13 weeks; rats were killed at 14 weeks. Coded liver section were assessed for fibrosis using a graded scale (0, no abnormal fibrosis to 4, early or established cirrhosis).
RESULTS: Rats that received antibiotics had significantly higher fibrosis scores than those that did not (mean score 2.4 vs 1.4, P < 0.01, ordinal logistic regression). Three rats, all of which were in the antibiotic group, were cirrhotic. Rats that had received antibiotics fell into three groups. Four had overgrowth of Proteus mirabilis; in these the fibrosis scores (mean 1.5) were similar to those in the rats that did not receive antibiotic. In six, no organisms could be cultured; fibrosis scores of these (mean 2.3) were slightly elevated (P = 0.03), but this was mainly because of a single rat in this subgroup being cirrhotic. The remaining eight had overgrowth of Morganella morganii; these had significantly (P < 0.001) elevated fibrosis scores. Furthermore, in this subgroup, fibrosis scores were significantly correlated (Spearman's r = 0.82, P = 0.01) with the number of weeks of Morganella colonization.
CONCLUSIONS: Antibiotic treatment exacerbated fibrosis in the alcohol/CCl4 rat model; this effect appeared to be related to the type of gut flora and may be endotoxin-mediated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129226

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats.

Authors:  Chun-Hui Li; Dong-Ming Piao; Wen-Xie Xu; Zheng-Ri Yin; Jing-Shun Jin; Zhe-Shi Shen
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Inhibitory effect of Huangqi Zhechong decoction on liver fibrosis in rat.

Authors:  Shuang-Suo Dang; Xiao-Li Jia; Yan-An Cheng; Yun-Ru Chen; En-Qi Liu; Zong-Fang Li
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

3.  Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis.

Authors:  Shun-Cai Zhang; Wei Wang; Wei-Ying Ren; Bo-Ming He; Kang Zhou; Wu-Nan Zhu
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

4.  Oral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition.

Authors:  Ming Li; Lin Zhu; Ao Xie; Jieli Yuan
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

5.  Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters.

Authors:  Virginie Lecomte; Nadeem O Kaakoush; Christopher A Maloney; Mukesh Raipuria; Karina D Huinao; Hazel M Mitchell; Margaret J Morris
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

6.  Bacterial isolation from internal organs of rats (Rattus rattus) captured in Baghdad city of Iraq.

Authors:  Nagham Mohammed Ayyal; Zainab Abdulzahra Abbas; Abdulkarim Jafar Karim; Zainab Majid Abbas; Karima Akool Al-Salihi; Jenan Mahmood Khalaf; Dunya Dhafir Mahmood; Eman Abdullah Mohammed; Rawaa Saladdin Jumaa; Dhuha Ismaeel Abdul-Majeed
Journal:  Vet World       Date:  2019-01-22

Review 7.  The Use of Rifaximin in Patients With Cirrhosis.

Authors:  Paolo Caraceni; Victor Vargas; Elsa Solà; Carlo Alessandria; Koos de Wit; Jonel Trebicka; Paolo Angeli; Rajeshwar P Mookerjee; François Durand; Elisa Pose; Aleksander Krag; Jasmohan S Bajaj; Ulrich Beuers; Pere Ginès
Journal:  Hepatology       Date:  2021-06-07       Impact factor: 17.425

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.